These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 777027)

  • 1. Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serum.
    Rosenfeld SI; Baum J; Steigbigel RT; Leddy JP
    J Clin Invest; 1976 Jun; 57(6):1635-43. PubMed ID: 777027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.
    Rosenfeld SI; Kelly ME; Leddy JP
    J Clin Invest; 1976 Jun; 57(6):1626-34. PubMed ID: 932197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary C6 deficiency in man.
    Frank MM; Leddy JP; Gaither T; Heusinkveld RS; Breckenridge RT; Klemperer MR
    Birth Defects Orig Artic Ser; 1975; 11(1):318-21. PubMed ID: 807274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary deficiency of the seventh component of complement.
    Boyer JT; Gall EP; Norman ME; Nilsson UR; Zimmerman TS
    J Clin Invest; 1975 Oct; 56(4):905-13. PubMed ID: 1099121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.
    Petersen BH; Graham JA; Brooks GF
    J Clin Invest; 1976 Feb; 57(2):283-90. PubMed ID: 815273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new semiquantitative radiometric opsonin assay. Selective measurement of opsonizing capacity of the alternative pathway.
    Yamamura M; Valdimarsson H
    Immunology; 1978 Apr; 34(4):689-94. PubMed ID: 363601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary complement C5 deficiency: study of 3 Tunisian adult cases and literature review].
    Zerzri Y; Kallel-Sellami M; Abdelmalek R; Laadhar L; Ben Chaabane T; Makni S
    Tunis Med; 2010 Apr; 88(4):269-76. PubMed ID: 20446263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
    Perez HD; Lipton M; Goldstein IM
    J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.
    Alper CA; Colten HR; Gear JS; Rabson AR; Rosen FS
    J Clin Invest; 1976 Jan; 57(1):222-9. PubMed ID: 1107355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary C5 deficiency in man. III. Studies of hemostasis and platelet responses to zymosan.
    Breckenridge RT; Rosenfeld SI; Graff KS; Leddy JP
    J Immunol; 1977 Jan; 118(1):12-6. PubMed ID: 830743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of a C7-inactivating principle.
    Wellek B; Opferkuch W
    Clin Exp Immunol; 1975 Feb; 19(2):223-35. PubMed ID: 813921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of a deficiency of the second component of complement on the bactericidal activity of neutrophils in vitro.
    Repine JE; Clawson CC; Friend PS
    J Clin Invest; 1977 May; 59(5):802-9. PubMed ID: 323290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus.
    Wild JH; Zvaifler NJ; Müller-Eberhard HJ; Wilson CB
    Clin Exp Immunol; 1976 May; 24(2):238-48. PubMed ID: 1084239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional abnormality of the fifth component of complement (C5) from human serum of individuals with a familial opsonic defect.
    Nilsson UR; Miller ME; Wyman S
    J Immunol; 1974 Mar; 112(3):1164-76. PubMed ID: 4204560
    [No Abstract]   [Full Text] [Related]  

  • 16. A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5).
    Miller ME; Nilsson UR
    N Engl J Med; 1970 Feb; 282(7):354-8. PubMed ID: 5411128
    [No Abstract]   [Full Text] [Related]  

  • 17. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent bacterial meningitis in patients with genetic defects of terminal complement components.
    Haeney MR; Thompson RA; Faulkner J; Mackintosh P; Ball AP
    Clin Exp Immunol; 1980 Apr; 40(1):16-24. PubMed ID: 7389212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
    Cunnion KM; Benjamin DK; Hester CG; Frank MM
    J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.